NVAX 주요 통계
고가
8.13
개시가
7.91
거래량
2.53M
저가
7.87
전일 종가
7.88
거래대금
20.33M
52주 최고가
11.97
상대 거래량
0.653
변동폭 (%)
3.30%
52주 최저가
6.20
회전율
1.54%
시가총액
1.29B
PER (TTM)
--
PER (연간)
2.897
PBR
-8.95
PSR
2.17
주당순이익(EPS)
-0.598
배당금(TTM)
0
배당수익률
0.00%
발행주식수
164.43M
통화 단위
USD
NVAX 가격 수익률
7 일
30 일
90 일
180 일
연초 이후
1 년
NVAX 자금 흐름 분포
NVAX 일일 공매도 거래량
NVAX 공매도 잔고 내역
NVAX 주식 스냅샷
As of 2026-07-22, the Novavax, Inc. (NVAX) stock price today is 8.075. Based on this price, the company has a market capitalization of $1.29B, with a P/E ratio of --.
On 2026-07-22, NVAX traded between 7.87 and 8.13. Today’s stock price is 2.60% above the daily low and 0.68% below the daily high, placing NVAX 높은 구간에 its most recent trading range.
Trading volume currently stands at 2.53M, compared with an average daily volume of 3.87M. This suggests that trading activity is 평소 수준을 밑도는 than usual.
Over the past year, Novavax, Inc. shares have traded between 6.20 and 11.97. At today’s price, NVAX is 30.24% above its 52-week low and 32.54% below its 52-week high.
NVAX 관련 뉴스
소개 NVAX
회사 이름
Novavax, Inc.
섹터
Health Technology
산업
Biotechnology
거래소
Nasdaq
직원 수
749
랏 크기
100
공식 웹사이트
통화 단위
USD
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Related Stocks
